Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets
Version of Record online: 18 MAR 2013
Copyright © 2013 American Society for Bone and Mineral Research
Journal of Bone and Mineral Research
Volume 28, Issue 4, pages 899–911, April 2013
How to Cite
Wöhrle, S., Henninger, C., Bonny, O., Thuery, A., Beluch, N., Hynes, N. E., Guagnano, V., Sellers, W. R., Hofmann, F., Kneissel, M. and Graus Porta, D. (2013), Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets. J Bone Miner Res, 28: 899–911. doi: 10.1002/jbmr.1810
- Issue online: 18 MAR 2013
- Version of Record online: 18 MAR 2013
- Accepted manuscript online: 5 NOV 2012 06:35PM EST
- Manuscript Accepted: 23 OCT 2012
- Manuscript Revised: 18 OCT 2012
- Manuscript Received: 15 MAY 2012
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.